French multinational company Danone has announced a 7% reduction in the wholesale price of its powdered Aptamil infant formula in the UK, effective from Monday. This move comes in response to an ongoing investigation by the country’s antitrust regulator, the Competition and Markets Authority (CMA), into the escalating prices within the infant formula market.
The CMA initiated the probe late last year after uncovering a 25% increase in baby formula prices over the past two years. The regulatory body also noted that 85% of the market is dominated by two companies, with Danone holding a substantial 70% market share. The investigation aims to comprehend consumer behavior, identify barriers to entry and expansion for formula makers, and assess whether regulatory changes are necessary.
Danone’s price reduction specifically applies to its powdered Aptamil formulas available in UK stores. However, it excludes liquid milks and the company’s other brand, Cow & Gate, according to a spokesperson for Danone.
The infant formula market is heavily regulated to guarantee infants receive safe and adequate nutrition. Interestingly, the CMA found minimal distinctions between various brands despite the range in prices.
Read more: Turkey Probes Nestlé, Danone For Price-Fixing
In response to the investigation’s commencement, a Danone spokesperson stated that the company had diligently worked to absorb cost increases, make savings, and minimize any price hikes. However, the spokesperson did not elaborate on the pricing discrepancy between Cow & Gate and Aptamil.
The CMA plans to release an update on its review in mid-2024, aiming to gain insights into consumer behavior and determine whether any regulatory adjustments are necessary. The investigation also reflects wider concerns about rising prices in the consumer goods sector across Europe, prompting political pressure and disputes between retailers and manufacturers.
As part of this broader trend, Danone’s decision to cut prices may serve as a proactive response to antitrust scrutiny, aligning with the broader industry’s need to address public concerns about affordability and fair competition. Meanwhile, the regulatory landscape remains a focal point, with the CMA poised to play a crucial role in shaping the future dynamics of the infant formula market.
Source: Fortune
Featured News
Judge Allows FTC Antitrust Case Against Amazon to Move Forward
Oct 1, 2024 by
CPI
SAP Leader Urges Caution on EU AI Rules, Warns of Competitive Disadvantage
Oct 1, 2024 by
CPI
Colorado’s Grocery Workers Unite to Oppose $24.6 Billion Supermarket Merge
Oct 1, 2024 by
CPI
Canada’s Competition Bureau Warns Businesses of Tougher Enforcement
Oct 1, 2024 by
CPI
Top Antitrust Lawyers Launch New Boutique Firm
Oct 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh